|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...5758596061626364656667...110111» |
- Ontak (denileukin diftitox) / Eisai, TSD Japan
Trial completion, Metastases: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine (clinicaltrials.gov) - Nov 12, 2014
P1, N=8, Completed, Sponsor: University of Washington
Active, not recruiting --> Completed
- || Enrollment closed: VIDIO: The Effects of Serum Vitamin D and IVF Outcome (clinicaltrials.gov) - Nov 11, 2014
P=N/A, N=490, Active, not recruiting, Sponsor: University of Birmingham
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist (clinicaltrials.gov) - Nov 11, 2014
P4, N=8, Terminated, Sponsor: Malcolm G. Munro
Recruiting --> Active, not recruiting N=40 --> 8 | Recruiting --> Terminated | Trial primary completion date: Jan 2013 --> Apr 2014; Inadequate enrollment
- clindamycin phosphate / Generic mfg.
Trial completion, Trial primary completion date: Treatment of Bacterial Vaginosis Combined With Human Lactobacilli (clinicaltrials.gov) - Nov 11, 2014
P4, N=75, Completed, Sponsor: Skaraborg Hospital
N=40 --> 8 | Recruiting --> Terminated | Trial primary completion date: Jan 2013 --> Apr 2014; Inadequate enrollment Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Oct 2014
- |||| clotrimazole topical / Generic mfg.
Enrollment open: Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis (clinicaltrials.gov) - Nov 7, 2014
P4, N=150, Recruiting, Sponsor: Medinova AG
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Oct 2014 Not yet recruiting --> Recruiting
- Enrollment open: Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial (clinicaltrials.gov) - Nov 7, 2014
P=N/A, N=600, Recruiting, Sponsor: University of Sao Paulo
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || Hepacid (pegargiminase) / Polaris Pharma
Trial primary completion date, Metastases: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma (clinicaltrials.gov) - Nov 7, 2014
P1, N=89, Recruiting, Sponsor: Polaris Group
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2014 --> Dec 2015
- Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Endometrial Scratching for Cryopreserved Embryo Transfer (clinicaltrials.gov) - Nov 7, 2014
P=N/A, N=0, Withdrawn, Sponsor: University of Sao Paulo
Trial primary completion date: Dec 2014 --> Dec 2015 N=200 --> 0 | Initiation date: Oct 2013 --> Jul 2013 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2014 --> Aug 2013
- ||| Trial completion, Trial primary completion date: Effect of Psychological Intervention on Drop-out Rates in IVF (clinicaltrials.gov) - Nov 6, 2014
P=N/A, N=166, Completed, Sponsor: Boston IVF
N=200 --> 0 | Initiation date: Oct 2013 --> Jul 2013 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2014 --> Aug 2013 Active, not recruiting --> Completed | Trial primary completion date: Sep 2013 --> Sep 2014
- clomifene citrate / Generic mfg.
Enrollment change, Trial withdrawal: Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate (clinicaltrials.gov) - Nov 6, 2014
P4, N=0, Withdrawn, Sponsor: University of British Columbia
Active, not recruiting --> Completed | Trial primary completion date: Sep 2013 --> Sep 2014 N=154 --> 0 | Recruiting --> Withdrawn
- clomifene citrate / Generic mfg.
Enrollment change: The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination (clinicaltrials.gov) - Nov 6, 2014
P4, N=95, Completed, Sponsor: Royan Institute
N=154 --> 0 | Recruiting --> Withdrawn N=154 --> 95
- Enrollment closed, Trial primary completion date: Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial (clinicaltrials.gov) - Nov 6, 2014
P4, N=300, Active, not recruiting, Sponsor: Rigshospitalet, Denmark
N=154 --> 95 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Mar 2015
- Enrollment open: Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation (clinicaltrials.gov) - Nov 5, 2014
P4, N=50, Recruiting, Sponsor: Rambam Health Care Campus
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Mar 2015 Not yet recruiting --> Recruiting
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Enrollment open, Trial initiation date: Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures (clinicaltrials.gov) - Nov 5, 2014
P4, N=100, Recruiting, Sponsor: Rambam Health Care Campus
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Feb 2014 --> Oct 2014
- Enrollment change, Trial termination, Trial primary completion date: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy (clinicaltrials.gov) - Nov 5, 2014
P3, N=32, Terminated, Sponsor: Xian-Janssen Pharmaceutical Ltd.
Not yet recruiting --> Recruiting | Initiation date: Feb 2014 --> Oct 2014 N=120 --> 32 | Recruiting --> Terminated | Trial primary completion date: Apr 2015 --> May 2014; the study was terminated due to medication supply issue from current manufacturer
- Enrollment closed, Adherence: Cervical Cancer Screening Among Hispanic Women (clinicaltrials.gov) - Nov 5, 2014
P=N/A, N=451, Active, not recruiting, Sponsor: Fred Hutchinson Cancer Research Center
N=120 --> 32 | Recruiting --> Terminated | Trial primary completion date: Apr 2015 --> May 2014; the study was terminated due to medication supply issue from current manufacturer Recruiting --> Active, not recruiting
- | cisplatin / Generic mfg., everolimus / Generic mfg.
Trial completion, Metastases: PHOENIX I: A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer (clinicaltrials.gov) - Nov 5, 2014
P1, N=14, Completed, Sponsor: Novartis Pharmaceuticals
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial primary completion date: MANI-PCOS: Mood and Nutrition Interventions in Polycystic Ovary Syndrome (clinicaltrials.gov) - Nov 4, 2014
P=N/A, N=50, Recruiting, Sponsor: University of Pennsylvania
Recruiting --> Completed Trial primary completion date: Nov 2014 --> Nov 2015
- ONT-10 / Seagen
Enrollment open, Metastases: Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer (clinicaltrials.gov) - Nov 4, 2014
P1, N=42, Recruiting, Sponsor: Oncothyreon Inc.
Trial primary completion date: Nov 2014 --> Nov 2015 Not yet recruiting --> Recruiting
- | New P1/2 trial, PD(L)-1 Biomarker, IO biomarker, Gene therapy: T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (clinicaltrials.gov) - Nov 3, 2014
P1/2, N=61, Recruiting, Sponsor: National Cancer Institute (NCI)
- | metformin / Generic mfg.
New P4 trial: Trial With Metformin in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Oct 31, 2014
P4, N=56, Completed, Sponsor: Herning Hospital
- || PF-06263507 / Pfizer
Trial primary completion date, Metastases: A Study Of PF-06263507 In Patients With Advanced Solid Tumors (clinicaltrials.gov) - Oct 31, 2014
P1, N=105, Recruiting, Sponsor: Pfizer
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2015 --> Apr 2016
- Trial primary completion date: Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Oct 31, 2014
P=N/A, N=114, Recruiting, Sponsor: British Columbia Cancer Agency
Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: Sep 2014 --> Jan 2015
- Trial primary completion date: Sexual Functioning After Primary Treatment of Ovarian Cancer (clinicaltrials.gov) - Oct 31, 2014
P=N/A, N=18, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Sep 2014 --> Jan 2015 Trial primary completion date: Nov 2014 --> Nov 2015
- || letrozole / Generic mfg.
Trial primary completion date: Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma (clinicaltrials.gov) - Oct 31, 2014
P2, N=80, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2014 --> Nov 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- PF-04691502 / Pfizer, gedatolisib (PF-05212384) / Celcuity
Enrollment change, Trial initiation date: A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer (clinicaltrials.gov) - Oct 31, 2014
P2, N=160, Terminated, Sponsor: Pfizer
Trial primary completion date: Dec 2015 --> Dec 2016 N=67 --> 160 | Initiation date: Jan 2012 --> Oct 2011
- ||||| New P4 trial: Alternate Dosing Schedules Study for HPV Vaccine (ADS) (clinicaltrials.gov) - Oct 31, 2014
P4, N=331, Completed, Sponsor: Duke University
- ||||| Orilissa (elagolix) / AbbVie
Trial initiation date: A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (clinicaltrials.gov) - Oct 30, 2014
P3, N=788, Recruiting, Sponsor: AbbVie
N=67 --> 160 | Initiation date: Jan 2012 --> Oct 2011 Initiation date: Sep 2013 --> May 2013
- medroxyprogesterone injection / Generic mfg.
Trial completion, Trial primary completion date: Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain (clinicaltrials.gov) - Oct 30, 2014
P4, N=112, Completed, Sponsor: Prince of Songkla University
Initiation date: Sep 2013 --> May 2013 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Apr 2011
- topotecan / Generic mfg., carboplatin / Generic mfg.
Enrollment change, Metastases: Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer (clinicaltrials.gov) - Oct 30, 2014
P1/2, N=12, Completed, Sponsor: ARCAGY/ GINECO GROUP
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Apr 2011 N=56 --> 12
- | Stivarga (regorafenib) / Bayer
New P2 trial: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer (clinicaltrials.gov) - Oct 30, 2014
P2, N=28, Not yet recruiting, Sponsor: University of Utah
- Enrollment open, Preclinical: Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy (clinicaltrials.gov) - Oct 30, 2014
P=N/A, N=20, Recruiting, Sponsor: Duke University
N=56 --> 12 Active, not recruiting --> Recruiting
- remifentanil / Generic mfg.
Trial completion, Trial primary completion date: ONSD According to the Position During Laparoscopy (clinicaltrials.gov) - Oct 30, 2014
P=N/A, N=60, Completed, Sponsor: Chosun University Hospital
Active, not recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2014
- thyroxine / Generic mfg.
Trial primary completion date: Selenium Supplementation in Pregnancy (clinicaltrials.gov) - Oct 28, 2014
P4, N=150, Recruiting, Sponsor: University of Roma La Sapienza
Recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2014 Trial primary completion date: May 2014 --> May 2015
- Trial completion: Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=2900, Completed, Sponsor: PATH
Trial primary completion date: May 2014 --> May 2015 Active, not recruiting --> Completed
- Trial completion: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=95, Completed, Sponsor: Children's Hospital of Philadelphia
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change: Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=1216, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Completed | N=2295 --> 1216
- || Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
New P2/3 trial, IO biomarker: Evaluation of Long Term Immunity Following HPV Vaccination (clinicaltrials.gov) - Oct 28, 2014
P2/3, N=200, Not yet recruiting, Sponsor: Murdoch Childrens Research Institute
- p53MVA - Tara I / O
New P1 trial, Combination therapy: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer (clinicaltrials.gov) - Oct 27, 2014
P1, N=9, Not yet recruiting, Sponsor: City of Hope Medical Center
- Orgalutran (ganirelix acetate) / Organon
Trial completion: Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation (clinicaltrials.gov) - Oct 27, 2014
P=N/A, N=15, Completed, Sponsor: Institut Universitari Dexeus
Recruiting --> Completed | N=2295 --> 1216 Recruiting --> Completed
- ||||| Menopur (menotropin) / Ferring
New P4 trial: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Oct 24, 2014
P4, N=150, Recruiting, Sponsor: Mansoura University
- cisplatin / Generic mfg.
Trial primary completion date, Metastases: DEPICT: Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer (clinicaltrials.gov) - Oct 24, 2014
P1/2, N=44, Recruiting, Sponsor: Queen Mary University of London
Recruiting --> Completed Trial primary completion date: Jul 2013 --> Jul 2015
- |||| Entereg (alvimopan) / Merck (MSD)
Trial primary completion date, Surgery: Accelerating Gastrointestinal Recovery (clinicaltrials.gov) - Oct 24, 2014
P3, N=134, Recruiting, Sponsor: Jamie N. Bakkum-Gamez
Trial primary completion date: Jul 2013 --> Jul 2015 Trial primary completion date: Mar 2015 --> Jun 2015
- || ethinyl estradiol/levonorgestrel / Generic mfg., naproxen / Generic mfg.
Trial primary completion date, HEOR: iTOM: Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (clinicaltrials.gov) - Oct 24, 2014
P4, N=120, Active, not recruiting, Sponsor: Abimbola Famuyide
Trial primary completion date: Mar 2015 --> Jun 2015 Trial primary completion date: Jan 2014 --> Dec 2014
- |||| anastrozole/levonorgestrel (BAY 98-7196) / Bayer
Enrollment open: Bay98-7196, Dose Finding / POC Study (clinicaltrials.gov) - Oct 24, 2014
P2b, N=324, Recruiting, Sponsor: Bayer
Trial primary completion date: Jan 2014 --> Dec 2014 Not yet recruiting --> Recruiting
- Trial completion, Trial primary completion date: An Intervention Study To Improve HPV Immunization in Haitian and African American Girls (clinicaltrials.gov) - Oct 24, 2014
P=N/A, N=200, Completed, Sponsor: Boston Medical Center
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Dec 2012 --> Oct 2013
- cabergoline / Generic mfg.
Phase classification, Trial primary completion date: Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Oct 22, 2014
P2/3, N=200, Recruiting, Sponsor: Benha University
Recruiting --> Completed | Trial primary completion date: Dec 2012 --> Oct 2013 Phase classification: P=N/A --> P2/3 | Trial primary completion date: Sep 2014 --> Dec 2014
- Clinical: Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=200, Enrolling by invitation, Sponsor: University of Alabama at Birmingham
- || Mifeprex (mifepristone) / Danco Laboratories
New P2/3 trial: Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis (clinicaltrials.gov) - Oct 22, 2014
P2/3, N=360, Completed, Sponsor: Mediterranea Medica S. L.
- || cabergoline / Generic mfg., calcium dobesilate monohydrate / Generic mfg.
New P2/3 trial: Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Oct 22, 2014
P2/3, N=220, Recruiting, Sponsor: Benha University